Oral Session 2-12D Ph+ALL

[OS2-12D-4] Different effect of BCR breakpoint on allo-HCT from different source for Ph+ALL in the era of TKI

Satoshi Nishiwaki¹, Shuichi Mizuta², Kazuteru Ohashi³, Takahiro Fukuda⁴, Naoyuki Uchida⁵, Heiwa Kanamori⁶, Makoto Onizuka⁷, Yukiyasu Ozawa⁸, Junji Tanaka⁹, Tatsuo Ichinohe¹⁰, Yoshiko Atsuta¹¹, Shinichi Kako¹² (1.Advanced Medicine, Nagoya Univ. Hospital, Nagoya, Japan, 2.Hematology & Immunology, Kanazawa Medical University, Kanazawa, Japan, 3.Hematology, Komagome Hospital, Tokyo, Japan, 4.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 5.Hematology, Toranomon Hospital, Tokyo, Japan, 6.Hematology, Kanagawa Cancer Center, Yokohama, Japan, 7.Hematology/Oncology, Tokai Univ., Isehara, Japan, 8.Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 9.Hematology, Tokyo Women's Medical Univ., Tokyo, Japan, 10.Hematology and Oncology, Hiroshima Univ., Hiroshima, Japan, 11.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 12.Hematology, Saitama Medical Center, Jichi Medical Univ., Saitama, Japan)